Followers
1
Following
1
Blog Posts
0
Threads
5,487
Blogs
Threads
Portfolio
Follower
Following
2019-10-11 17:28 | Report Abuse
The Group recorded revenue of RM9.63 million for the current quarter under review compared to RM8.06 million for the
preceding quarter. The increase of 19.5% was mainly due to higher sales contribution from House Brand segment under
the functional food category namely ActivMax and sales contribution from clinical trial for Hepar-P.
http://www.bursamalaysia.com/market/listed-companies/company-announcements/6263521
2019-10-10 21:03 | Report Abuse
Once Nova product hepar-p passes all clinical tests, the share price will boom a few folds.
2019-10-10 19:32 | Report Abuse
Look like VT buying again last minutes today. Good new is he is accumulating. He never sold it.
2019-10-10 19:28 | Report Abuse
Dont be afraid, I support kahhoeng. Just do it.
2019-10-10 11:36 | Report Abuse
Wrong statement. Look at privatization of BJ Capital and BJ Details lah. Only now we need to think whether he can continue such a good deed or not after so many years.
2019-10-09 12:20 | Report Abuse
I keep most. some sell and buy . Ha ha. Do you trade too?
2019-10-09 11:50 | Report Abuse
30/9, 1/10, 2/10, 3/10, 4/10 VT buys everyday.
2019-10-08 19:34 | Report Abuse
I suggest you attend AGM. You will get a lot of vitamins. Nova had generously given last year.
Posted by Miz Raya Bloom > Oct 8, 2019 11:57 AM | Report Abuse
I need vitamins!
2019-10-08 19:32 | Report Abuse
AA FORUM SO HOT TODAY. GOING TO BOOM LAH!
2019-10-08 15:02 | Report Abuse
Can kahhoeng repost the comment:
kahhoeng Why is my comment questioning the BURSA/SC failure to protect minorities be deleted?
08/10/2019 9:41 AM here?
2019-10-08 08:18 | Report Abuse
In Penta deal, Bjland worth 38 cents while Bjcorp worth 30 cents. That is very much different.
2019-10-08 07:54 | Report Abuse
Shareholders of international fund managers will not let it go easily. No worry.
2019-10-07 09:05 | Report Abuse
法师有提醒VT, must always be generous and helpful.
2019-10-05 12:27 | Report Abuse
Disobeyance will make VT in big trouble.
2019-10-05 12:25 | Report Abuse
Bursa will enforce strict rules and regulations to all VT public listed companies
2019-10-05 12:18 | Report Abuse
Dont make Bursa angru machai. Bursa is the taiko.
2019-10-05 12:15 | Report Abuse
Bursa: We will appoint an independent advisor, pls follow lah for your sakes and all.
2019-10-05 12:12 | Report Abuse
Bursa: Before you are blacklisted. You have given me a lot of headaches. Vietnam properties sold without early announcements. Srr these complaints on my table like aa mountain. Alll complaint against you.
2019-10-05 12:08 | Report Abuse
Bursa: You future companies listings approval are our decision. Do as I said, before are blacklisted.
2019-10-05 12:06 | Report Abuse
Bursa: Listen. We dont allow anymore lower public shareholding. You decide to cooperate. All your public listed companies BJCorp, BJMedia... still here. You know what to do.
2019-10-05 12:03 | Report Abuse
VT: But I still want to continue buying at low price lah you know, very undervalue.
2019-10-05 11:54 | Report Abuse
You better offer them now with a good price.
2019-10-05 11:53 | Report Abuse
Bursa: I have been looking after you VT, by allowing lower public shareholding for 9 years but this has caused many small shareholders unhappy. They are also my clients.
2019-10-05 11:45 | Report Abuse
Bursa Chairman has already talked to VT. Dont need black and white. You help me, I help you.
2019-10-05 11:43 | Report Abuse
Harassing others. Lip ypur Master lah
2019-10-05 10:49 | Report Abuse
Not all need black and white, Soi Toi.
2019-10-05 10:48 | Report Abuse
Has you listened to Bursa conversation to VT?
2019-10-05 10:48 | Report Abuse
How do you know? Are you Bursa? You are not.
2019-10-05 10:40 | Report Abuse
Go to lip your Master, stockraider.
Stock: [NOVA]: NOVA WELLNESS GROUP BERHAD
2019-10-11 17:32 | Report Abuse
Clinical trial of Hepar-P Capsule ( is for the treatment of non-alcoholic fatty liver disease.
2015
Completed the first clinical trial of Hepar-P Capsule for the treatment of non-alcoholic fatty liver disease.
2017
Ready for the second clinical trial of Hepar-P Capsule for the treatment of non-alcoholic fatty liver disease.
http://nova.my/history